PCSK9 and Hypercholesterolemia: Gain-of-function PCSK9 variants have been identified as missense mutations in the coding region, intronic junctions, as well as in the promoter region that increase PCSK9 transcription and are associated with hypercholesterolemia and coronary heart disease (CHD) (128).